Sign In  |  Register  |  About Pleasanton  |  Contact Us

Pleasanton, CA
September 01, 2020 1:32pm
7-Day Forecast | Traffic
  • Search Hotels in Pleasanton

  • ROOMS:

CannabisNewsBreaks – Green Hygienics Holdings Inc. (GRYN) Names Former J&J Director as New Chief Scientific Officer

Green Hygienics (OTCQB: GRYN), an innovative, technology-driven enterprise focused on the high-standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids, has announced that Dr. Francesca Serraino Fiory will serve as the company’s new chief scientific officer. In her new role, Fiory will manage product development, including GRYN’s multibrand portfolio, and oversee research and development efforts under TruLife Biotech, the company’s wholly owned subsidiary. In addition, she will head up partnerships with both academic institutions and research centers and will navigate the company across the global regulatory landscape. Fiory has worked for several major players in the pharmaceutical industry including Pfizer, where she started in regulatory and medical affairs; Johnson and Johnson (“J&J”), where she was head of regulatory and medical affairs at Johnson & Johnson Consumer Health Care, Italy; and Perrigo Pharma, where she was director of regulatory, quality and medical affairs and also supervised the Italian affiliate’s portfolio, which included medicinal products, cosmetic products, medical devices, food supplements, biocides and veterinary products. A certified nutritional consultant, clinical master herbalist and aromatherapist, and a certified holistic health practitioner in traditional Chinese medicine, Fiory brings with her 20-plus years of expertise and an impressive knowledge of the pharmaceutical environment, medicinal products, herbals, medical devices, cosmetics and food supplements.

To view the full press release, visit

About Green Hygienics Holdings Inc.

Green Hygienics is a California-based innovative, technology-driven enterprise focused on the high-standard cultivation and processing of industrial hemp and manufacturing of pharmaceutical-grade bioactive cannabinoids. The company’s corporate mission is to adhere to the highest standards of operations in consistently delivering safe and premium-quality products to consumers as well as to partner with consumer packaged goods (“CPG”) and pharmaceutical companies. For more information about the company, visit

NOTE TO INVESTORS: The latest news and updates relating to GRYN are available in the company’s newsroom at

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published:

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
303.498.7722 Office

CannabisNewsWire is part of the InvestorBrandNetwork.

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Photography by Christophe Tomatis
Copyright © 2010-2020 & California Media Partners, LLC. All rights reserved.